Cambridge Investment Research Advisors, Inc. - ASSERTIO THERAPEUTICS INC ownership

ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 94 filers reported holding ASSERTIO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of ASSERTIO THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$182,000
-69.4%
145,568
+44.1%
0.00%
-83.3%
Q3 2018$594,000101,0030.01%
Other shareholders
ASSERTIO THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Virtus ETF Advisers LLC 64,315$326,0000.69%
PERKINS CAPITAL MANAGEMENT INC 130,600$662,0000.44%
Senvest Management, LLC 1,000,140$5,071,0000.38%
Matarin Capital Management, LLC 827,462$4,195,0000.30%
DELTEC ASSET MANAGEMENT LLC 271,543$1,377,0000.30%
GLOBEFLEX CAPITAL L P 214,103$1,086,0000.23%
TSP Capital Management Group, LLC 58,050$294,0000.15%
Spark Investment Management LLC 538,443$2,729,0000.13%
Connor, Clark & Lunn Investment Management Ltd. 3,134,905$15,894,0000.10%
FIRST QUADRANT LLC/CA 245,756$1,246,0000.10%
View complete list of ASSERTIO THERAPEUTICS INC shareholders